CompletedNot Applicable

Urine Albumin/Creatinine Ratio and Renal Function Differences in Phenotypes of Polycystic Ovary Syndrome.

Turkey (Türkiye)300 participantsStarted 2022-04-01

Plain-language summary

Since there are different metabolic effects in different phenotypes of polycystic ovary syndrome (PCOS); in this study; the investigators aimed to investigate whether there is a difference between glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (ACR) levels in different PCOS phenotypes and compare healthy controls.

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients who applied for reasons such as hair growth, acne, menstrual irregularity or infertility and were diagnosed with PCOS after examination, biochemical, hormonal and sonographic tests,
✓. Female patients between the ages of 18-35,
✓. Patients without known cancer, liver or kidney failure,
✓. Patients who do not take drugs, ACEIs and ARBs.
✓. Female patients without active infection will be included. -

Exclusion criteria

✕. Female patients \<18 years of age and \>35 years of age,
✕. Patients with known cancer, liver and kidney failure,
✕. Patients taking drugs, ACEIs and ARBs,
✕. Patients with active infection will not be included in the study. -

What they're measuring

Urine albumin/creatinine ratio

Timeframe: Eight months

glomerular filtration rate

Timeframe: Eight months

Trial details

NCT IDNCT07441811

SponsorUşak University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials